These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20087178)

  • 1. Nontuberculous mycobacterial lung disease.
    Griffith DE
    Curr Opin Infect Dis; 2010 Apr; 23(2):185-90. PubMed ID: 20087178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.
    Lee MR; Yang CY; Shu CC; Lin CK; Wen YF; Lee SW; Ko JC; Wang JY; Lee LN; Yu CJ
    Clin Microbiol Infect; 2015 Mar; 21(3):250.e1-7. PubMed ID: 25658545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.
    Aksamit TR; Philley JV; Griffith DE
    Respir Med; 2014 Mar; 108(3):417-25. PubMed ID: 24484653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of refractory nontuberculous mycobacterial lung disease.
    Griffith DE; Aksamit TR
    Curr Opin Infect Dis; 2012 Apr; 25(2):218-27. PubMed ID: 22327466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung disease caused by nontuberculous mycobacteria.
    Alvarez-Uria G
    Curr Opin Pulm Med; 2010 May; 16(3):251-6. PubMed ID: 20154623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.
    Kunst H; Wickremasinghe M; Wells A; Wilson R
    Eur Respir J; 2006 Aug; 28(2):352-7. PubMed ID: 16611651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nontuberculous mycobacterial lung infections].
    Chuard C; Erard V
    Rev Med Suisse; 2011 Oct; 7(312):1982-4, 1986-7. PubMed ID: 22097449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
    Griffith DE; Wallace RJ
    Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.
    Choi H; Jhun BW; Kim SY; Kim DH; Lee H; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):293-295. PubMed ID: 29329759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.
    Stout JE
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):981-93. PubMed ID: 17181415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand.
    Chetchotisakd P; Kiertiburanakul S; Mootsikapun P; Assanasen S; Chaiwarith R; Anunnatsiri S
    Clin Infect Dis; 2007 Aug; 45(4):421-7. PubMed ID: 17638188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of nontuberculous mycobacterial disease in New Zealand, 2004.
    Freeman J; Morris A; Blackmore T; Hammer D; Munroe S; McKnight L
    N Z Med J; 2007 Jun; 120(1256):U2580. PubMed ID: 17589548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary manifestations of nontuberculous Mycobacterium.
    Patz EF; Swensen SJ; Erasmus J
    Radiol Clin North Am; 1995 Jul; 33(4):719-29. PubMed ID: 7610241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
    Koh WJ; Stout JE; Yew WW
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.